References
- Alberti, K., Echel, H., Grundy, M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J. C., James, W. P., Loria, C. M., Smith, S. C. Jr. (2009). Harmonizing the metabolic syndrome. Circulation, 120, 1640–1645.
- Amin, S., Zhang, Y., Sawin, C. T., Evans, S. R., Hannan, M. T., Kiel, D. P., Wilson, P. W., Felson, D. T. (2000). Association of hypogonadism and estradiol levels with bone mineral density in elderly. Ann. Intern. Med., 133 (12), 951–963.
- Anonymous (1996). The European Vertebral Osteoporosis Study. J. Bone Miner Res, 11, 1010–1018.
- Anonymous (1999). European Study Group for the Study of Insulin Resistance (EGIR). Diabet Med., 16, 442–444.
- Anonymous (2000). WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation (WHO Technical Report Series 894). Geneva, pp. 8–9.
- Anonymous (2018). Overweight and obesity: BMI statistics. Eurostat. Available at: http://ec.europa.eu/eurostat/statistics-explained/index.php?title=Overweight_and_obesity_-_BMI_statistics (accessed 21.08.2018).
- Atlantis, E., Fahey, P., Cochrane, B., Wittert, G, Smith, S. (2013). Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis. BMJ Open, 3 (8).
- Barrett-Connor, E., Goodman-Gruen, D. (1995). Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ, 311 (7014), 1193–1200.
- Barrett-Connor, E., Von Mühlen, D. G., Kritz-Silverstein, D. (1999). Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study. J. Clin. Endocrinol. Metab., 84 (2), 573–577.
- Blaya, R., Thomaz, L. D., Guilhermano, F., Paludo Ade, O., Rhoden, L., Halmenschlager, G., Rhoden, E. L. (2016). Total testosterone levels are correlated to metabolic syndrome components. Aging Male, 19 (2), 85–89.
- Butrova, S. (1999). Syndrome of insulin resistance in abdominal obesity [Бутрова, С. Синдром инсулинрезистентности при абдоминальном ожирении]. Lechashchi vrach, 7, 32-34 (in Russian).
- Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., Khosla, S. (2000). Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J. Clin. Invest., 106, 1553–1560.
- Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J. Urol., 151 (1), 54–61.
- Feldman, I. R., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., McKinlay, J. B. (2002). Age trends in the level of serum testosterone and other hormones in middle aged men: Longitudinal results from the Massachusetts Male aging study. J. Clin. Endocrinol. Metab., 87 (2), 87–92.
- Ferrando, A. A., Sheffield-Moore, M., Yeckel, C. W., Gilkison, C., Jiang, J., Achacosa, A., Lieberman, S. A., Tipton, K., Wolfe, R. R., Urban, R. J. (2002). Urban testosterone administration to older men improves muscle function: Molecular and physiological mechanisms. Amer. J. Physiol. Endocrinol. Metab., 282, 601–607.
- Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., Vardi, Y., Wespes, E. (2010). Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur. Urol., 57 (5), 804–814.
- Isidori, A. M., Caprio, M., Strollo, E., Moretti, C., Frajese, G., Isidori, A., Fabbri, A. (1999). Leptin and androgens in male obesity: Evidence for leptin contribution to reduced androgen level. J. Clin. Endocrinol. Metab., 84, 3673–3680.
- Isidori, A. M., Giannetta, E., Pozza, C., Bonifacio, V., Isidori, A. (2005). Androgens, cardiovascular disease and osteoporosis. J. Endocrinol. Invest, 28 (10 Suppl), 73–79.
- Jockenhovel, F. (1999). Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men. Metabolism, 48 (5), 590–596.
- Jockenhovel, F. (2004). Male Hypogonadism. Germany International Medical Publishers, Bremen. 188 pp.
- Kahraman, H., Sen, B., Koksal, N., Kilinē, M., Resim, S. (2013). Erectile dysfunction and sex hormone changes in chronic obstructive pulmonary disease patients. Multidiscip. Respir. Med., 8 (1), 66.
- Kaiser, F. E., Morley, J. E. (1994). Gonadotropins, testosterone, and the aging male. Neurobiol Aging, 15 (4), 559–563.
- Karakou, E., Glynos, C., Samara, K. D., Msaouel, P., Koutsilieris, M., Vassilakopoulos, T. (2013). Profile of endocrinological derangements affecting PSA values in patients with COPD. In Vivo, 27 (5), 641–649.
- Kasperk, C. H., Wergedal, J. E., Farley, J. R., Linkhart, T. A., Turner, R. T., Baylink, D. J. (1989). Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology, 124, 1576–1578.
- Katznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., Klibanski, A. (1996). Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab., 81 (12), 4358–4365.
- Keasl, J. R. (1999). The autonomic nerve supply of male sex organs an important target of circulating androgens. Behav. Brain Res., 105 (1), 81–92.
- Khaiv, K. T., Barrett-Connor, E. (1991). Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin. Sci. (Lond.), 80 (3), 199–203.
- Laughlin, G. A., Barrett-Connor, E., Bergstrom, J. (2008). Low serum testosterone and mortality in older men. J. Clin. Endocrinol. Metab., 93 (1), 68–75.
- Lester, J. F., Mason, M. D. (2015). Cardiovascular effects of hormone therapy for prostate cancer. Drug Healthcare Patient Saf., 7, 129–138.
- Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., Morgentalerm, A. (2015). Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male,18 (1) 5–15.
- Mancia, G., Fagard, R., Narkevich, K. et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur. Heart J.,34 (28), 2159–2219.
- Morales, A., Lunenfeld, Ā. (2002). International Society for the Study of the Aging Male. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male, 5 (2), 74–86.
- Ohlsson, C., Barrett-Connor, E., Bhasin, S., Orwoll, E., Labrie F,, Karlsson, M. K., Ljunggren, O., Vandenput, L., Mellström, D., Tivesten, A. (2011). High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden, 58 (16), 1674–1681.
- O’Neiil, T. W., Felsenderg, D., Verlaw, J., Cooper, C., Kanis, J. A., Silman, A. J. (1996). The prevalence of vertebral deformity in European man and women: The European Vertebral Osteoporosis Study. J. Bone Miner Res, 11, 1010–1018.
- Phillips, G. B., Pinkernell, B. H., Jing, T. Y. (1994). The association of hy-potestosteronemia with coronary artery disease in men. Arterioscler Thromb, 14 (5), 701–706.
- Požarskis, A., Ērenpreiss, J. (2010). Late-onset hypogonadism: Review of the problem. Proceedings of the Latvian Academy of Sciences, Section B, 64 (3/4), 93–99.
- Reisman, Y., Porst, H., Lowenstein, L., Tripodi, F, Kirana, P. S. (2015). The ESSM Manual of Sexual Medicine. Medix, Amsterdam. 369 pp.
- Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J., Peńa, B. M. (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res., 11 (6), 319–326.
- Schweiger, U., Deuschle, M., Weber, B., Körner, A., Lammers, C. H., Schmider, J., Gotthardt, U., Heuser, I. (1999). Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom. Med., 61 (3), 292–296.
- Sib, R., Morley, F. E., Kaiser, F. E., Perry, H. M. 3rd, Patrick, P., Ross, C. (1997). Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J. Clin. Endocrinol. Metab., 82 (6), 1661–1667.
- Simon, D., Charles, M. A., Nahoul, K., Orssaud, G., Kremski, J., Hully, V., Joubert, E., Papoz, L., Eschwege, E. (1997). Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J. Clin. Endocrinol. Metab., 82 (2), 682–685.
- Tajar, A., Huhtaniemi, I. T., O’Neill, T. W., Finn, J. D., Pye, S. R., Lee, D. M., Bartfai, G., Boonen, S., Casanueva, F. F., Forti, G., Giwercman, A., Han, T. S., Kula, K., Labrie, F., Lean, M. E., Pendleton, N., Punab, M., Vanderschueren, D., Wu, F. C. (2012). Characteristics of androgen deficiency in late-onset hypogonadism: Results from the European Male Aging Study (EMAS). J. Clin. Endocrinol. Metab., 97 (5), 1508–1516.
- Takahashi, J., Higashi, Y., LaNasa, J. A., Yoshida, K., Winters, S. J., Oshima, H., Troen, P. (1983). Studies of the human testis. XVIII. Simultaneous measurement of nine intratesticular steroids: Evidence for reduced mitochondrial function in testis of elderly men. J. Clin. Endocrinol. Metab., 56 (6), 1178–1187.
- Tchernof, A., Labrie, F., Belanger, A., Prud’homme, D., Bouchard, C., Tremblay, A., Nadeau, A., Després, J. P. (1997). Androstane-3alpha, 17 betadiol glucuronide as a steroid correlate of visceral obesity in men. J. Clin. Endocrinol. Metab., 82 (5), 1528–1534.
- Tenover, J. S. (1992). Effects of testosterone supplementation in the ageing male. J. Clin. Endocrinol. Metab., 75, 1092–1098.
- Tenover, J. S., Matsumoto, A. M., Plymate, S. R., Bremner, W. J. (1987). The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate. J. Endocrinol. Metab., 65, 1118–1126.
- Tenover, J. L. (1998). Male hormone replacement therapy including “andro-pause”. Endocrin. Metab. Clin. North Amer., 27, 969–987.
- Tibblin, G., Adlerberth, A., Lindstedt, G., Bjorntorp, P. (1996). The pituitary- gonadal axis and health in elderly men: A study of men born in 1913. Diabetes, 45 (11), 1605–1609.
- Tivesten, Å., Vandenput, L., Carlzon, D., Nilsson, M., Karlsson, M. K., Ljunggren, Ö., Barrett-Connor, E., Mellström, D., Ohlsson, C. (2014). Dehydroepiandrosterone and its sulphate predict the5-year risk of coronary heart disease events in elderly men. J. Amer. Coll. Cardiol., 64 (17), 1801–1810.
- Tonutti, E. (1954). Qualitative and quantitative effect of chorionic gonadotropin on the testicular structure. Sem. Hop, 30 (34), 2135–2142.
- Tran Van, P., Baron, R., Vignery, A. (1982). Cellular kinetics of the bone remodelling sequence in the rat. Anat. Rec., 202, 441–451.
- Tran Van, P., Vignery, A., Baron, R. (1982). An electron microscopic study of the bone remodelling sequence in the rat. Cell Tissue Res., 225, 283–292.
- Van den Beld, A. W., Bots, M., Janssen, J. A., Pols, H. A. P., Lamberts, S. W. J., Grobbee, D. E. (2003). Endogenous hormones and carotid atherosclerosis in elderly men. Amer. J. Epidemiol., 157 (1), 25–31.
- Vanderschueren, D., VanHerck, E., Nijs, J., Ederveen, A. G., De Coster, R., Bouillon, R. (1997). Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology, 138, 2301–2307.
- Velazquez, E. M., Mendoza, S. G., Wang, P., Glueck, C. J. (1997). Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism, 46 (4), 454.
- Veldhuis, J. D., Metzger, D. L., Martha, P. M. (Jr.), Mauras, N., Kerrigan, J. R., Keenan, B., Rogol, A. D., Pincus, S. M. (1997). Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement. J. Clin. Endocrinol. Metab., 82 (10), 3414–3420.
- Veldhuis, J. D., Urban, R. J., Lizarralde, G., Johnson, M. L., Iranmanesh, A. (1992). Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J. Clin. Endocrinol. Metab., 75 (3), 707–713.
- Vermeulen, A. (2001). Androgen replacement therapy in the aging males critical evaluation. J. Clin. Endocrinol. Metab., 86 (6), 2380–2390.
- Vermeulen, A. (1991). Androgens in the aging male. J. Clin. Endocrinol. Metab., 73, 221–224.
- Vermeulen, A., Verdonck, L., Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol Metab., 84 (10), 3666–3672.
- Vertkin, A. L., Morgunov, L. I., Shakhmanaev, Kh. A. (2013). Hypogonadism and chronic obstructive pulmonary disease. Urologiia, No. 5, 116–118, 120–122 (in Russian).
- Von Eckardstein, A., Kliesch, S., Nieschlag, E. (1997). Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J. Clin. Endocrinol. Metab., 82 (10), 3367–3372.
- Von Schoultz, B., Carlström, K. (1989). On the regulation of sex-hormone- binding globulin: A challenge of an old dogma and outlines of an alternative mechanism. J. Steroid Biochem., 32 (2), 327–334.
- Vestbo, I., Hurd, S. S., Agusti, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., Stockley, R. A., Sin, D. D., Rodriguez-Roisin, R. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Amer. J. Respir. Crit. Care Med., 187 (4), 347–365.
- Wakley, G. K., Schutte, (Jr.) H. D., Hannon, K. S., Turner, R. T. (1991). Androgen treatment prevents loss of cancellous bone in the orchidectomized rat. J. Bone Miner Res, 6, 325–330.
- Walker, T. C. (1942). Use of testosterone propionate and estrogenic sub-stance in treatment of essential hypertension, angina pectoris and peripheral vascular disease. J. Clin. Endocrinol., 2, 560–568.
- Wallock-Montelius, L. M., Villanueva, J. A., Chapin, R. E., Conley, A. J., Nguyen, H. P., Ames, B. N., Halsted, C. H. (2007). Chronic ethanol perturbs testicular folate metabolism and dietary folate deficiency reduces sex hormone levels in the Yucatan micropig. Bill. Reprod., 76 (3), 455–465.
- Wang, C., Nieschlag, E., Swerdloff, R., Behre, H., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J. J., Lunenfeld, B., Morales, A., Morley, J. E., Schulman, C., Thompson, I. M., Weidner, W., Wu, F. C. (2009). ISA, ISSAM, EAU, EAA and ASA Recommendations: Investigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males. Int. J. Impot. Res., 21 (1), 1–8.
- Watson, R. R., Huls, A., Araghinikuam M., Chung, S. (1996). Dehydro-epiandrosterone and diseases of aging. Drugs Aging, 9 (4), 274–291.
- Williamson, D. A., Perrin, L. A. (1996). Behavioural therapy for obesity. Endocrinol. Metab. Clin. North Amer., 25 (4), 943–954.
- Yassin, A. A., Saad, F. (2007). Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J. Sex Med., 4 (2), 497–501.
- Zitzmann, M., Nieschlag, E. (2003). Hypogonadism in the elderly man. Reliable diagnosis and therapy. Internist, 44 (10), 1313–1321 (in German).